Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$101.99 - $166.36 $1.15 Million - $1.87 Million
-11,245 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $923,090 - $1.17 Million
6,519 Added 137.94%
11,245 $1.86 Million
Q1 2021

May 14, 2021

SELL
$132.81 - $182.18 $360,711 - $494,800
-2,716 Reduced 36.5%
4,726 $659,000
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $685,599 - $914,695
4,962 Added 200.08%
7,442 $1.29 Million
Q3 2020

Nov 12, 2020

BUY
$114.09 - $145.51 $282,943 - $360,864
2,480 New
2,480 $345,000
Q3 2018

Nov 13, 2018

SELL
$44.22 - $75.47 $145,262 - $247,918
-3,285 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $23,016 - $29,415
318 Added 10.72%
3,285 $262,000
Q4 2017

Feb 09, 2018

SELL
$65.94 - $93.31 $2,241 - $3,172
-34 Reduced 1.13%
2,967 $204,000
Q3 2017

Nov 14, 2017

BUY
$80.87 - $91.08 $242,690 - $273,331
3,001
3,001 $273,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $140M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.